Dr. Sofanit Getahun is a Safety Evaluator, with the Division of Medication Error Prevention and Analysis1 (DMEPA 1), Office of Medication Error Prevention and Risk Mitigation (OMEPRM), Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research (CDER), at the U.S. Food and Drug Administration (FDA). Dr. Getahun is part of multidisciplinary team responsible for reviewing and analyzing medication errors and providing expertise within FDA and to external organizations to assess the risk of medication errors throughout a product’s lifecycle, from preapproval to post approval.

Dr. Getahun earned her degree of Doctor of Pharmacy from the University of Maryland Baltimore School of Pharmacy in 2006. She has been a practicing clinical pharmacist for the past 17 years. Prior to joining the Agency, she has worked at the University of Maryland Medical Center in Baltimore (UMMC) and The Children’s National Hospital in Washington, DC. At UMMC she has worked at numerous levels within the pharmacy department. In 2018 she transitioned to The Children’s National Hospital in Washington, DC where she is currently active as a clinical pharmacist.